AstraZeneca Says its Coronavirus Vaccine Candidate Shows 70% Average Efficacy
AstraZeneca, a multinational pharmaceutical company with a Gaithersburg campus, announced Monday that its COVID-19 vaccine candidate shows a 70% average efficacy rate. The vaccine candidate AZD1222 was administered in two… Read More